|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hayashi M, Yamada S, Takano N, Okamura Y,
Takami H, Inokawa Y, Sonohara F, Tanaka N, Shimizu D, Hattori N, et
al: Different characteristics of serum alfa fetoprotein and serum
des-gamma-carboxy prothrombin in resected hepatocellular carcinoma.
In Vivo. 35:1749–1760. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Taura N, Ichikawa T, Miyaaki H, Ozawa E,
Tsutsumi T, Tsuruta S, Kato Y, Goto T, Kinoshita N, Fukushima M, et
al: Frequency of elevated biomarkers in patients with cryptogenic
hepatocellular carcinoma. Med Sci Monit. 19:742–750.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tameda M, Shiraki K, Sugimoto K, Ogura S,
Inagaki Y, Yamamoto N, Ikejiri M, Takei Y, Ito M and Nobori T:
Des-γ-carboxy prothrombin ratio measured by P-11 and P-16
antibodies is a novel biomarker for hepatocellular carcinoma.
Cancer Sci. 104:725–731. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kang KH, Kim JH, Kang SH, Lee BJ, Seo YS,
Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT and Byun KS: The influence
of alcoholic liver disease on serum PIVKA-II levels in patients
without hepatocellular carcinoma. Gut Liver. 9:224–230.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Ohhira M, Saito H, Suzuki Y, Naraki T,
Sakurai S, Ohtake T, Suzuki M, Ohhira M, Fujimoto Y and Kohgo Y: A
variant of des-gamma-carboxy prothrombin was increased in alcoholic
liver disease without hepatocellular carcinoma. Alcohol Clin Exp
Res. 25 (6 Suppl):46S–50S. 2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yan C, Hu J, Yang J, Chen Z, Li H, Wei L,
Zhang W, Xing H, Sang G, Wang X, et al: Serum ARCHITECT PIVKA-II
reference interval in healthy Chinese adults: Sub-analysis from a
prospective multicenter study. Clin Biochem. 54:32–36.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Booth SL: Skeletal functions of vitamin
K-dependent proteins: Not just for clotting anymore. Nutr Rev.
55:282–284. 1997.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Szulc P, Chapuy MC, Meunier PJ and Delmas
PD: Serum undercarboxylated osteocalcin is a marker of the risk of
hip fracture in elderly women. J Clin Invest. 91:1769–1774.
1993.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kuwabara A, Fujii M, Kawai N, Tozawa K,
Kido S and Tanaka K: Bone is more susceptible to vitamin K
deficiency than liver in the institutionalized elderly. Asia Pac J
Clin Nutr. 20:50–55. 2011.PubMed/NCBI
|
|
12
|
Booth SL, Martini L, Peterson JW, Saltzman
E, Dallal GE and Wood RJ: Dietary phylloquinone depletion and
repletion in older women. J Nutr. 133:2565–2569. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lin X, Brennan-Speranza TC, Levinger I and
Yeap BB: Undercarboxylated osteocalcin: Experimental and human
evidence for a role in glucose homeostasis and muscle regulation of
insulin sensitivity. Nutrients. 10(847)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lee SW, Jo HH, Kim MR, Kim JH and You YO:
Association between osteocalcin and metabolic syndrome in
postmenopausal women. Arch Gynecol Obstet. 292:673–681.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Iki M, Tamaki J, Fujita Y, Kouda K, Yura
A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N and Kurumatani
N: Serum undercarboxylated osteocalcin levels are inversely
associated with glycemic status and insulin resistance in an
elderly Japanese male population: Fujiwara-kyo osteoporosis risk in
men (FORMEN) study. Osteoporos Int. 23:761–770. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xia M, Rong S, Zhu X, Yan H, Chang X, Sun
X, Zeng H, Li X, Zhang L, Chen L, et al: Osteocalcin and
non-alcoholic fatty liver disease: Lessons from two
population-based cohorts and animal models. J Bone Miner Res.
36:712–728. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Strople J, Lovell G and Heubi J:
Prevalence of subclinical vitamin k deficiency in cholestatic liver
disease. J Pediatr Gastroenterol Nutr. 49:78–84. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mager DR, McGee PL, Furuya KN and Roberts
EA: Prevalence of vitamin K deficiency in children with mild to
moderate chronic liver disease. J Pediatr Gastroenterol Nutr.
42:71–76. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shah NL, Northup PG and Caldwell SH: A
clinical survey of bleeding, thrombosis, and blood product use in
decompensated cirrhosis patients. Ann Hepatol. 11:686–690.
2012.PubMed/NCBI
|
|
20
|
Bunchorntavakul C and Reddy KR: Review
article: Malnutrition/sarcopenia and frailty in patients with
cirrhosis. Aliment Pharmacol Ther. 51:64–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ehnert S, Aspera-Werz RH, Ruoß M, Dooley
S, Hengstler JG, Nadalin S, Relja B, Badke A and Nussler AK:
Hepatic osteodystrophy-molecular mechanisms proposed to favor its
development. Int J Mol Sci. 20(2555)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Niezen S, Tapper EB, Trivedi H, Lai M,
Curry MP, Mukamal KJ and Jiang ZG: Prevalence of high liver
stiffness and a screening strategy using the SODA-2B score among US
adults. Hepatol Commun. 6:898–909. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shephard DA: The 1975 Declaration of
Helsinki and consent. Can Med Assoc J. 115:1191–1192.
1976.PubMed/NCBI
|
|
24
|
Nishikawa H, Shiraki M, Hiramatsu A,
Moriya K, Hino K and Nishiguchi S: Japan Society of Hepatology
guidelines for sarcopenia in liver disease (1st edition):
Recommendation from the working group for creation of sarcopenia
assessment criteria. Hepatol Res. 46:951–963. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Malmstrom TK and Morley JE: SARC-F: A
simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir
Assoc. 14:531–532. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Child CG and Turcotte JG: Surgery and
portal hypertension. Major Probl Clin Surg. 1:1–85. 1964.PubMed/NCBI
|
|
27
|
Johnson PJ, Berhane S, Kagebayashi C,
Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A,
Palmer D, et al: Assessment of liver function in patients with
hepatocellular carcinoma: A new evidence-based approach-the albi
grade. J Clin Oncol. 33:550–558. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kamath P, Wiesner RH, Malinchoc M, Kremers
W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER and Kim WR: A
model to predict survival in patients with end-stage liver disease.
Hepatology. 33:464–470. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Vallet-Pichard A, Mallet V, Nalpas B,
Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H and Pol S:
FIB-4: An inexpensive and accurate marker of fibrosis in HCV
infection. comparison with liver biopsy and fibrotest. Hepatology.
46:32–36. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A:
Collaborators developing the Japanese equation for estimated GFR.
Revised equations for estimated GFR from serum creatinine in Japan.
Am J Kidney Dis. 53:982–992. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kashani KB, Frazee EN, Kukrálová L,
Sarvottam K, Herasevich V, Young PM, Kashyap R and Lieske JC:
Evaluating muscle mass by using markers of kidney function:
Development of the sarcopenia index. Crit Care Med. 45:e23–e29.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi
Y, Yamashima M, Yamamichi S, Koike M, Takahashi Y, Honda T, Yajima
H, et al: Indices calculated by serum creatinine and cystatin C as
predictors of liver damage, muscle strength and sarcopenia in liver
disease. Biomed Rep. 12:89–98. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kim SW, Jung HW, Kim CH, Kim KI, Chin HJ
and Lee H: A new equation to estimate muscle mass from creatinine
and cystatin C. PLoS One. 11(e0148495)2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rodrigues FG, Ormanji MS, Heilberg IP,
Bakker SJL and de Borst MH: Interplay between gut microbiota, bone
health and vascular calcification in chronic kidney disease. Eur J
Clin Invest. 51(e13588)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ozaki D, Kubota R, Maeno T, Abdelhakim M
and Hitosugi N: Association between gut microbiota, bone
metabolism, and fracture risk in postmenopausal Japanese women.
Osteoporos Int. 32:145–156. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Milosevic I, Vujovic A, Barac A, Djelic M,
Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic
V, Lekic N, et al: Gut-liver axis, gut microbiota, and its
modulation in the management of liver diseases: A review of the
literature. Int J Mol Sci. 20(395)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Moro-Sibilot L, Blanc P, Taillardet M,
Bardel E, Couillault C, Boschetti G, Traverse-Glehen A, Defrance T,
Kaiserlian D and Dubois B: Mouse and human liver contain
immunoglobulin A-secreting cells originating from peyer's patches
and directed against intestinal antigens. Gastroenterology.
151:311–323. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Trebicka J, Bork P, Krag A and Arumugam M:
Utilizing the gut microbiome in decompensated cirrhosis and
acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol.
18:167–180. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Doi H, Hayashi E, Arai J, Tojo M, Morikawa
K, Eguchi J, Ito T, Kanto T, Kaplan DE and Yoshida H: Enhanced
B-cell differentiation driven by advanced cirrhosis resulting in
hyperglobulinemia. J Gastroenterol Hepatol. 33:1667–1676.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gabr SA and Alghadir AH: Handgrip strength
and vitamin D as predictors of liver fibrosis and malnutrition in
chronic hepatitis C patients. Dis Markers.
2021(6665893)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
van Ballegooijen AJ, Beulens JWJ, Kieneker
LM, de Borst MH, Gansevoort RT, Kema IP, Schurgers LJ, Vervloet MG
and Bakker SJL: Combined low vitamin D and K status amplifies
mortality risk: A prospective study. Eur J Nutr. 60:1645–1654.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kuroda T, Uenishi K, Ohta H and Shiraki M:
Multiple vitamin deficiencies additively increase the risk of
incident fractures in Japanese postmenopausal women. Osteoporos
Int. 30:593–599. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Edwards MH, Dennison EM, Aihie Sayer A,
Fielding R and Cooper C: Osteoporosis and sarcopenia in older age.
Bone. 80:126–130. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Binkley N and Buehring B: Beyond FRAX:
It's time to consider ‘sarco-osteopenia’. J Clin Densitom.
12:413–416. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Saeki C and Tsubota A: Influencing factors
and molecular pathogenesis of sarcopenia and osteosarcopenia in
chronic liver disease. Life (Basel). 11(899)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wester A, Ndegwa N and Hagström H: Risk of
fractures and subsequent mortality in alcohol-related cirrhosis: A
nationwide population-based cohort study. Clin Gastroenterol
Hepatol. 21:1271–1280.e7. 2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Levinger I, Brennan-Speranza TC, Zulli A,
Parker L, Lin X, Lewis JR and Yeap BB: Multifaceted interaction of
bone, muscle, lifestyle interventions and metabolic and
cardiovascular disease: Role of osteocalcin. Osteoporos Int.
28:2265–2273. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Carson JA and Manolagas SC: Effects of sex
steroids on bones and muscles: Similarities, parallels, and
putative interactions in health and disease. Bone. 80:67–78.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Tarantino G, Balsano C, Santini SJ,
Brienza G, Clemente I, Cosimini B and Sinatti G: It is high time
physicians thought of natural products for alleviating NAFLD. Is
there sufficient evidence to use them? Int J Mol Sci.
22(13424)2021.PubMed/NCBI View Article : Google Scholar
|
